Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
Christoph Schuhmacher(Heidelberg University), Peter M. Schlag(Charité - Universitätsmedizin Berlin), Katja Ott(Technical University of Munich), Wolf O. Bechstein(Unknown), Peter Reichardt(Helios Hospital Berlin-Buch), Florian Lordick(Leipzig University), Arnulf H. Hoelscher(Heidelberg University), Manfred P. Lutz(Universitätsklinikum des Saarlandes), Claus Ferdinand Eisenberger(Heidelberg University), Paul M. Schneider(Heidelberg University), Eric Van Cutsem(Universitair Ziekenhuis Leuven), Cornelie Haag(Heidelberg University), Werner Hohenberger(Universitätsklinikum Erlangen), Murielle Mauer(Heidelberg University), Bernard Nordlinger(Académie Nationale de Médecine), Baktiar Hasan(Heidelberg University), Stephan Gretschel(Heidelberg University), H. Wilke(Heidelberg University), John J. Welch(University of Cambridge)
Cited by 714
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Gastric cancer
|The Lancet|2020|4.8k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k